Case Study: Injectable Artesunate Uptake

Published August 11th, 2015

Treating severe malaria with injectable artesunate instead of quinine can substantially reduce mortality. To increase uptake and improve health outcomes, CHAI supported ministries of health in six high-burden countries to overcome barriers to adoption. Learn more about CHAI’s work to increase update and reduce severe malaria mortality in this case study.